1. Genetic basis of clinical catecholamine disorders. Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D (2002) Ann N Y Acad Sci : 506-14
    › Primary publication · 12438171 (PubMed)
  2. Developing novel treatments for mood disorders: accelerating discovery. Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM, Paul SM, Rudorfer MV, Sausville E, Schatzberg AF, Scolnick EM, Suppes T (2002) Biol Psychiatry 52(6): 589-609
    › Primary publication · 12361670 (PubMed)
  3. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. Bauman PA, Blakely RD (2002) Arch Biochem Biophys 404(1): 80-91
    › Primary publication · 12127072 (PubMed)
  4. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Serafeim A, Grafton G, Chamba A, Gregory CD, Blakely RD, Bowery NG, Barnes NM, Gordon J (2002) Blood 99(7): 2545-53
    › Primary publication · 11895792 (PubMed)
  5. Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. Apparsundaram S, Sung U, Price RD, Blakely RD (2001) J Pharmacol Exp Ther 299(2): 666-77
    › Primary publication · 11602680 (PubMed)
  6. The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders. Belous AR, Ramamoorthy S, Blakely RD, Factor MI, Dupin AM, Katasonov AB, Lozier RH, Beniashvili AG, Morozova MA, Brusov OS (2001) Neurosci Behav Physiol 31(2): 185-9
    › Primary publication · 11392354 (PubMed)
  7. Physiological genomics of antidepressant targets: keeping the periphery in mind. Blakely RD (2001) J Neurosci 21(21): 8319-23
    › Primary publication · 11606618 (PubMed) · PMC6762804 (PubMed Central)
  8. Neurobiology. Dopamine's reversal of fortune. Blakely RD (2001) Science 293(5539): 2407-9
    › Primary publication · 11577225 (PubMed)
  9. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Apparsundaram S, Ferguson SM, Blakely RD (2001) Biochem Soc Trans 29(Pt 6): 711-6
    › Primary publication · 11709061 (PubMed)
  10. Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Adkins EM, Barker EL, Blakely RD (2001) Mol Pharmacol 59(3): 514-23
    › Primary publication · 11179447 (PubMed)